Compugen Valuation
| CGEN Stock | ILA 711.20 3.20 0.45% |
At this time, the firm appears to be fairly valued. Compugen shows a prevailing Real Value of 712.25 per share. The current price of the firm is 711.2. Our model approximates the value of Compugen from analyzing the firm fundamentals such as Shares Owned By Insiders of 5.50 %, current valuation of 12.53 M, and Return On Equity of -0.44 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Compugen's price fluctuation is very steady at this time. Calculation of the real value of Compugen is based on 3 months time horizon. Increasing Compugen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Compugen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Compugen Stock. However, Compugen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 711.2 | Real 712.25 | Hype 711.2 | Naive 667.77 |
The real value of Compugen Stock, also known as its intrinsic value, is the underlying worth of Compugen Company, which is reflected in its stock price. It is based on Compugen's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Compugen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Compugen helps investors to forecast how Compugen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Compugen more accurately as focusing exclusively on Compugen's fundamentals will not take into account other important factors: Compugen Total Value Analysis
Compugen is currently forecasted to have takeover price of 12.53 M with market capitalization of 251.35 M, debt of 2.85 M, and cash on hands of 110.41 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Compugen fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
12.53 M | 251.35 M | 2.85 M | 110.41 M |
Compugen Investor Information
About 28.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.13. Some equities with similar Price to Book (P/B) outperform the market in the long run. Compugen recorded a loss per share of 0.4. The entity had not issued any dividends in recent years. Based on the analysis of Compugen's profitability, liquidity, and operating efficiency, Compugen is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Compugen Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Compugen has an asset utilization ratio of 4.54 percent. This suggests that the Company is making 0.0454 for each dollar of assets. An increasing asset utilization means that Compugen is more efficient with each dollar of assets it utilizes for everyday operations.Compugen Ownership Allocation
Compugen holds a total of 86.62 Million outstanding shares. Compugen shows 5.5 percent of its outstanding shares held by insiders and 27.56 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Compugen Profitability Analysis
The company reported the revenue of 6 M. Net Loss for the year was (34.2 M) with profit before overhead, payroll, taxes, and interest of 5.32 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Compugen's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Compugen and how it compares across the competition.
About Compugen Valuation
The stock valuation mechanism determines Compugen's current worth on a weekly basis. Our valuation model uses a comparative analysis of Compugen. We calculate exposure to Compugen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Compugen's related companies.Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the United States, and Europe. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel. COMPUGEN operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 68 people.
8 Steps to conduct Compugen's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Compugen's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Compugen's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Compugen's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Compugen's revenue streams: Identify Compugen's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Compugen's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Compugen's growth potential: Evaluate Compugen's management, business model, and growth potential.
- Determine Compugen's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Compugen's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Compugen Stock analysis
When running Compugen's price analysis, check to measure Compugen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compugen is operating at the current time. Most of Compugen's value examination focuses on studying past and present price action to predict the probability of Compugen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compugen's price. Additionally, you may evaluate how the addition of Compugen to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |